Page last updated: 2024-09-03

ezogabine and Muscular Diseases

ezogabine has been researched along with Muscular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chabwine, JN; Démonet, JF; du Pasquier, RA; Hirt, L; Kuntzer, T; Michel, P; Rossetti, AR; Schluep, M; Vingerhoets, FG	1
Greenwood, IA; Jepps, TA; Olesen, SP	1

Reviews

1 review(s) available for ezogabine and Muscular Diseases

Article	Year
One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders. British journal of pharmacology, 2013, Volume: 168, Issue:1 Topics: Animals; Anticonvulsants; Carbamates; Constipation; Female; Humans; Hypertension; KCNQ1 Potassium Channel; Membrane Potentials; Membrane Transport Modulators; Muscle Tonus; Muscle, Smooth; Muscle, Smooth, Vascular; Muscular Diseases; Neurons; Obstetric Labor, Premature; Phenylenediamines; Potassium Channels, Voltage-Gated; Pregnancy; Urinary Bladder Diseases	2013

Article

Year

One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.

British journal of pharmacology, 2013, Volume: 168, Issue:1

Topics: Animals; Anticonvulsants; Carbamates; Constipation; Female; Humans; Hypertension; KCNQ1 Potassium Channel; Membrane Potentials; Membrane Transport Modulators; Muscle Tonus; Muscle, Smooth; Muscle, Smooth, Vascular; Muscular Diseases; Neurons; Obstetric Labor, Premature; Phenylenediamines; Potassium Channels, Voltage-Gated; Pregnancy; Urinary Bladder Diseases

2013

Other Studies

1 other study(ies) available for ezogabine and Muscular Diseases

Article	Year
[Neurology]. Revue medicale suisse, 2012, Jan-11, Volume: 8, Issue:323 Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid	2012

Article

Year

[Neurology].

Revue medicale suisse, 2012, Jan-11, Volume: 8, Issue:323

Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid

2012